A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...

In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.

Just over half of the eligible population had the Covid-19 booster, with experts keen to see it given alongside the annual flu vaccine.

The Food and Drug Administration's decision, made public on Feb. 10, to not review an application to approve Moderna's proposed mRNA-based flu vaccine set off a firestorm of criticism from public ...

A "new" virus in California has reached New Jersey as cases of HMPV in NJ have spiked in recent days, with the human metapneumovirus (HMPV) having no treatment and no vaccine, according to the Centers ...

New Jersey is seeing a surge in cases of human metapneumovirus, aka HMPV. The rise in HMPV cases, plus the number of RSV, COVID, and flu cases in New Jersey, has led to the number of people seeking ...

Europe’s drug-review committee has recommended approval of the first combined flu and COVID vaccine designed for adults 50 years and older. If regulators confirm the decision, one injection could ...

Adults in England aged 50 years or older who received the bivalent BA.1 mRNA booster vaccine during the 2022 autumn campaign had substantially lower risks for COVID-related hospitalisation and death ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

European regulators gave the green light to Moderna Inc. ’s novel combination flu and Covid shot, handing a victory to the embattled vaccine maker as it struggles to get the same shot approved in the ...

Moderna seeks to return to growth Its share price has lost 90% from pandemic peaks Anti-vaccine health secretary has disrupted US vaccine policy Feb 27 (Reuters) - Europe's medicines regulator ...

On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European regulators, which opens the door for the vaccine’s approval in the European ...